Nashville Biosciences leverages Vanderbilt University Medical Center’s massive, de-identified biobank (BioVU®) to provide life science companies with deep genomic and real-world clinical data. By linking millions of longitudinal electronic health records to genetic data, Nashville Biosciences accelerates drug discovery, target validation, and clinical trial optimization for precision medicine.